Shelton Capital Management Charles River Laboratories International, Inc. Transaction History

Shelton Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $816,027 - $1.03 Million	-2,774 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $15,762 - $17,936	-71 Reduced 2.5%	2,774 $693,000
Q2 2020 Aug 12, 2020	SELL	$118.84 - $189.72 $17,588 - $28,078	-148 Reduced 4.94%	2,845 $496,000
Q1 2020 May 13, 2020	SELL	$98.9 - $178.34 $15,032 - $27,107	-152 Reduced 4.83%	2,993 $378,000
Q4 2019 Feb 11, 2020	SELL	$126.05 - $152.76 $16,008 - $19,400	-127 Reduced 3.88%	3,145 $480,000
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $342,064 - $411,780	2,772 Added 554.4%	3,272 $464,000
Q1 2019 May 10, 2019	SELL	$104.82 - $146.73 $308,380 - $431,679	-2,942 Reduced 85.47%	500 $3.44 Million
Q3 2017 Nov 28, 2017	BUY	$96.72 - $109.26 $332,910 - $376,072	3,442 New	3,442 $372,000
Q3 2017 Nov 14, 2017	SELL	$96.72 - $109.26 $332,910 - $376,072	-3,442 Closed	0 $0
Q4 2016 Nov 29, 2017	SELL	N/A	-1,370 Reduced 28.47%	3,442 $262,000
Q3 2016 Dec 06, 2017	BUY	N/A	1,370 Added 39.8%	4,812 $401,000
Q3 2016 Dec 04, 2017	BUY	N/A	3,442	3,442 $262,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.